NASDAQ:SLP Simulations Plus Q4 2026 Earnings Report $18.50 +0.01 (+0.05%) Closing price 04:00 PM EasternExtended Trading$18.50 0.00 (-0.03%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Simulations Plus EPS ResultsActual EPSN/AConsensus EPS $0.09Beat/MissN/AOne Year Ago EPSN/ASimulations Plus Revenue ResultsActual RevenueN/AExpected Revenue$17.44 millionBeat/MissN/AYoY Revenue GrowthN/ASimulations Plus Announcement DetailsQuarterQ4 2026Date10/29/2026TimeAfter Market ClosesConference Call DateFriday, October 23, 2026Conference Call Time4:00PM ETConference Call ResourcesEarnings HistoryCompany Profile Simulations Plus Earnings HeadlinesSimulations Plus, Inc. (NASDAQ:SLP) Stock Has Average Price Target of $17.25September 25, 2026 | americanbankingnews.comCritical Analysis: Maravai LifeSciences (NASDAQ:MRVI) vs. Simulations Plus (NASDAQ:SLP)September 22, 2026 | americanbankingnews.comThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percent run, and Nvidia before it climbed more than 50,000 percent. Now Chaikin says a new AI data center technology using 99 percent less electricity, water, and space could accelerate scientific breakthroughs 360-fold, and one company behind it just flashed bullish in his system. See the full research and the ticker Chaikin is watching before this presentation goes offline.October 2 at 1:00 AM | Chaikin Analytics (Ad)Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET PredictorSeptember 18, 2026 | finance.yahoo.comSimulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science BranchSeptember 17, 2026 | businesswire.comJohnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting DisclosuresSeptember 10, 2026 | globenewswire.comSee More Simulations Plus Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Simulations Plus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Simulations Plus and other key companies, straight to your email. Email Address About Simulations PlusSimulations Plus (NASDAQ:SLP) develops software and provides consulting services for pharmaceutical and biotechnology companies involved in drug discovery and development. Its modeling and simulation tools are designed to help researchers evaluate drug candidates, understand how medicines move through the body, assess safety risks and support decisions throughout the development process. The company’s products include GastroPlus, a platform used for physiologically based pharmacokinetic and biopharmaceutic modeling; ADMET Predictor, which helps predict absorption, distribution, metabolism, excretion and toxicity characteristics; and DILIsym, a software platform focused on drug-induced liver injury. Simulations Plus also offers additional modeling tools and scientific services covering pharmacokinetics, pharmacodynamics, toxicology and related areas. Founded in 1996, Simulations Plus serves pharmaceutical and biotechnology companies, contract research organizations, regulatory agencies and academic institutions. Its customer base is international, reflecting the company’s role in supporting drug research and development across major global pharmaceutical markets.View Simulations Plus ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market Share Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
